Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, April 06, 2022
Asymchem Laboratories (Tianjin) Co., Ltd. announced the company has completed construction of a new building at its Dunhua, China, production site. The expansion will add nearly 500m³ of batch capacity to meet demands for upcoming commercialization ...
read more
Wednesday, March 31, 2021
Asymchem has announced a dedicated expansion of API manufacturing facilities to provide clients with peptide and oligonucleotide products.
read more
Monday, February 09, 2015
Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 60 years, will introduce a new label + cap combination anti-counterfeiting solution to the U.S. market at INTERPHEX NYC 2015 Booth #1053, ...
read more
Thursday, January 08, 2015
Bob Hartwig, North American Representative for DIR Technologies – a provider of quality and process control solutions for pharmaceutical primary packaging – will deliver a presentation at Pack Expo East on the potential of disruptive technology and ...
read more
Thursday, January 27, 2022
Atara Biotherapeutics, Inc. has entered into a long term strategic agreement with FUJIFILM Diosynth Biotechnologies (FDB), a subsidiary of FUJIFILM Corporation under which Fujifilm will acquire Atara’s T-Cell Operations and Manufacturing (ATOM) ...
read more
Today, ATS Labs, Inc. (ATS), majority owned by Ampersand Capital
Partners, announced that it acquired the assets of MicroTest Labs, Inc. (MTL) of Agawam, MA. The
acquisition of MTL is the first step in the strategy of ATS to expand its microbiology...
read more
ATUM and Phylex BioSciences have entered into a collaboration to leverage ATUM's Leap-In Transposase® platform to develop the cell line essential to the manufacturing of Phylex's universal SARS coronavirus vaccine candidate.
read more
August Bioservices,LLC, a contract development and manufacturing organization (CDMO) providing drug discovery, development, and pharmaceutical manufacturing services, closed a $23.6 million Series A extension, led by Polaris Partners, who joined ...
read more
Wednesday, December 30, 2020
Aurinia Pharmaceuticals and Lonza have expanded their exclusive manufacturing relationship.
read more
Autolus Therapeutics are further expanding their operations at the CGT Catapult manufacturing centre.
read more
Avacta Group plc, the developer of diagnostics and innovative cancer therapies based on its proprietary Affimer® and pre|CISION™ platforms, announced that it has received notice of registration of its AffiDX® SARS-CoV-2 antigen lateral flow test in ...
read more
Wednesday, August 12, 2020
Avacta Group has appointed BBI Solutions to manufacture the saliva-based rapid SARS-CoV-2 antigen test that is being developed with Cytiva.
read more
Wednesday, September 02, 2020
Avacta Group has entered into an agreement with Abingdon Health for the manufacture of Avacta’s saliva-based rapid SARS-CoV-2 antigen test as part of its ongoing expansion of manufacturing capacity.
read more
Avacta has announce the first Affimer-based rapid test strips to detect SARS-COV-2 spike protein have been developed and evaluated by Avacta’s partners at Cytiva and show positive initial performance data.
read more
Wednesday, February 10, 2021
Avacta and Mologic have entered into a commercial partnership to accelerate to market Avacta’s AffiDX SARS-CoV-2 lateral flow rapid antigen test.
read more